​

Biohaven (BHVN) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Biohaven Revenue Highlights

00

Biohaven Revenue by Period

Biohaven Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31--100.00%
2021-12-31$462.51M100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2017-12-31--

Biohaven generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Biohaven Revenue by Quarter

DateRevenueChange
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$3.84M100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31--100.00%
2022-12-31$-215.08M100.00%
2022-09-30--100.00%
2022-06-30$215.08M-32.55%
2022-03-31$318.85M67.81%
2021-12-31$190.01M39.98%
2021-09-30$135.74M46.06%
2021-06-30$92.93M112.06%
2021-03-31$43.82M24.80%
2020-12-31$35.11M98.79%
2020-09-30$17.66M82.14%
2020-06-30$9.70M742.57%
2020-03-31$1.15M100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31--

Biohaven generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Biohaven Revenue Breakdown

Biohaven Revenue Breakdown by Product

Quarterly Revenue by Product

Product/ServiceJun 22Mar 22
Product$193.95M$123.59M
Collaboration And Other-$195.26M

Biohaven's latest quarterly revenue breakdown by segment (product or service), as of Jun 22: Product (100.00%).

Biohaven Revenue Breakdown by Country

Quarterly Revenue by Country

CountryJun 22Mar 22
Product$193.95M$123.59M
Collaboration And Other-$195.26M

Biohaven's latest quarterly revenue breakdown by geography, as of Jun 22: Product (100.00%).

Biohaven Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
APLSApellis Pharmaceuticals$709.95M$171.39M
BPMCBlueprint Medicines$508.82M$149.41M
ARVNArvinas$263.40M$22.40M
BBIOBridgeBio Pharma$221.90M$71.50M
AMLXAmylyx Pharmaceuticals$87.37M-
PRTGPortage Biotech--
BHVNBiohaven--
DNLIDenali Therapeutics--

BHVN Revenue FAQ

What is Biohaven’s yearly revenue?

Biohaven's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. BHVN's yearly revenue for 2022 was $0, representing a decrease of -100.00% compared to 2021.

What is Biohaven’s quarterly revenue?

Biohaven's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). BHVN's quarterly revenue for Q4 2024 was $3.84M, a 100.00% increase from the previous quarter (Q3 2024), and a 0% increase year-over-year (Q4 2023).

What is Biohaven’s revenue growth rate?

Biohaven's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.